2:00 p.m. - 6:00 p.m.
|
Conference Registration - Front Lobby of Hotel |
6:00 p.m. - 9:00 p.m. |
Cocktail Reception and Dinner with Presentation: "A Tribute to William Krivit" |
|
Saturday, June 24, 2006 |
7:00 a.m. - 8:15 a.m. |
Conference Registration/Full Breakfast |
|
8:15 a.m. |
Welcome, Greg Macres (CGRF)
Session 1. Basic science - pathological mechanisms.
Chairs: Tony Futerman Ph.D. and Col. Kondi Wong M.D.
|
|
8:30 a.m. |
"Overview of pathological mechanisms in sphingolipid storage disease of the brain"
Tony Futerman Ph.D. (Weizmann Institute of Science) |
|
8:50 a.m. |
"GM1-ganglioside as mediator of ER-stress-and mitochondria-elicited neuronal apoptosis"
Sandro D'Azzo Ph.D. (St. Jude Children's Research Hospital ) |
|
9:35 a.m. |
"TRP-ML channels and the function of intracellular organelles" Shmuel Muallem Ph.D.
(Univ. of Texas Southwestern Medical Ctr ) |
|
10:20 a.m. |
Coffee Break |
|
10:50 a.m. |
"A conditional knockout mouse model for Gaucher disease"
Francis Choy Ph.D. (University of Victoria)
Lorne Clarke M.D. (Univ. of British Columbia)
|
|
11:20 a.m. |
"Molecular findings in the brain of Gaucher disease mouse model based on expression
analysis"
Sung-Chul Jung M.D. Ph.D. (Ewha Womans University) |
|
11:50 a.m. |
"Novel mouse models for type 1 and type 2 Gaucher disease for use in the development
of new therapies"
Stefan Karlsson M.D. Ph.D. (Lund University Hospital ) |
|
12:20 p.m. |
Lunch |
|
1:05 p.m. |
"Pathogenic mechanisms that underlie Juvenile Batten Disease"
David A. Pearce Ph.D. (Univ. of Rochester School of Medicine)
|
|
1:50 p.m. |
"Impact of systemic inflammation on chronic neurodegenerative disease"
Hugh Perry MA DPhil FMedSci (Univ of Southampton) |
|
2:35 p.m. |
Concluding remarks. "Developments since the 2004 conference?"
Greg Grabowski M.D. (Children's Hos. Research Foundation) |
3:00 p.m. - 5:00 p.m. |
Poster Session |
6:00 p.m. - 9:30 p.m. |
Cocktail Reception/Dinner
Presentation: "Gaucher Disease & Parkinsonism - Is There a Connection"
Ellen Sidransky M.D. (National Institutes of Health, NHGRI)
Matt Farrer Ph.D. (Mayo Clinic, Jacksonville Florida)
Panel Discussion: "Is There a Connection"
|
|
Sunday, June 25, 2006 |
7:00 a.m. - 8:15 a.m. |
Full Breakfast |
|
8:15 a.m. |
Session 2. LSD therapy.
Chairs Roscoe Brady M.D. / Raphael Schiffmann M.D. |
|
8:15 a.m. |
"Overview of therapeutic options"
Roscoe Brady M.D. |
|
8:30 a.m. |
"Functional correction of CNS phenotypes in a lysosomal storage disease model using
adeno-associated virus type 4 vectors"
Beverly L. Davidson Ph.D. (Roy J. Carver Professor - University of Iowa) |
|
9:15 a.m. |
"Intracranial delivery of CLN2 in LINCL"
Ronald G. Crystal M.D. (Weill Med. College of Cornell University) |
|
10:00 a.m. |
Coffee Break |
|
10:30 a.m. |
"Therapy and pathogenesis of metachromatic leukodystrophy: Studies in a mouse model"
Volkmar Gieselman M.D. (University of Bonn) |
|
11:15 a.m. |
"Combined therapy for the treatment of globoid cell leukodystrophy"
David Wenger Ph.D. (Jefferson Medical College) |
|
12:00 p.m |
Lunch |
|
12:30 p.m. |
"Understanding and ameliorating misfolding diseases"
Jeffrey W. Kelley Ph.D. (The Scripps Research Institute, La Jolla, California) |
|
1:15 p.m. |
"Cell- Fusion as a Tool for Generating a Neurological Disease Model 8"
Ehud Goldin Ph.D. (National Inst of Health - NHGRI ) |
|
2:00 p.m. |
"Stem cell research and the brain - relevance for LSDs"
Evan Snyder M.D. Ph.D. (Burnham Institute for Med. Research, La Jolla, Ca) |
|
2:45 p.m. |
Concluding remarks. "Therapy - what's on the horizon?"
Raphael Schiffmann M.D. |